Patent · US Active

Multispecific constructs

US10047163B2 · kind B2 · utility

2Cited by
4References
3Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 7, 2014
Grant dateAug 14, 2018
Priority date
Expiry dateApr 30, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are novel multispecific antibody constructs and multispecific antibody drug conjugates (ADCs), and methods of using such antibodies and ADCs to treat cancer. IgG-like bispecific antibodies have different binding specificities on each arm of the antibody. They are similar in structure to monospecific IgGs in that they contain two heavy chains with VH, CH1, CH2 and CH3 regions, and two light chains with VL and CL regions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.